Header Logo

Connection

KENNETH R HESS to Memantine

Back to Details
This is a "connection" page, showing publications KENNETH R HESS has written about Memantine.
KENNETH R HESS
Connection Strength
0.164
Memantine
  1. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. Cancer. 2019 02 01; 125(3):424-433.
    View in: PubMed
    Score: 0.164
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.